Ligand Pharmaceuticals Inc

Ligand Pharmaceuticals Inc is a leading biopharmaceutical company that specializes in the development and commercialization of innovative medicines for the treatment of various diseases. With a diverse portfolio of products that target cancer, inflammation, and metabolic disorders, Ligand's proprietary technologies enable the discovery and development of new drugs. The company's business model is based on partnerships with other pharmaceutical companies, which license its technologies and products for development and commercialization. Ligand's flagship product, Captisol, is a patented technology that enhances the solubility and stability of drugs, making them more effective and easier to administer. Committed to advancing the field of medicine through innovative research and development programs, Ligand's mission is to improve the lives of patients worldwide.